Lenvatinib Suppresses Angiogenesis through the Inhibition of both the VEGFR and FGFR Signaling Pathways

Global Journal of Cancer Therapy
Research Article
Lenvatinib mesilate (lenvatinib) is an oral multiple-receptor tyrosine kinase inhibitor that selectively inhibits the kinase activities of Vascular Endothelial Growth Factor Receptor (VEGFR) 1-3, Fibroblast Growth Factor Receptor (FGFR) 1-4, Platelet-Derived Growth Factor Receptor (PDGFR) a, KIT, and RET. 
http://www.peertechz.com/Cancer-Therapy/pdf/GJCT-2-109.pdf

Comments

Post a Comment

Popular posts from this blog

Case Report: Reynolds Syndrome

International Journal of Dermatology and Clinical Research Case Report Reynolds et al. described in 1971, 6 patients with classical primary biliary cholangitis, who presented concomitantly with varying degrees of scleroderma. Since then this association has been called Reynolds Syndrome.  https://www.peertechz.com/articles/case-report-reynolds-syndrome.pdf  #ReynoldsSyndrome#
Read more

Successful treatment of Budd- Chiari Syndrome with Percutaneous transluminal Balloon Angioplasty

Journal of Cardiovascular Medicine and Cardiology Case Report Introduction: Budd-Chiari syndrome (BCS) is a relatively rare disease in which an obstruction of hepatic venous outfl ow causes intrahepatic venous congestion and portal hypertension.     https://www.peertechz.com/articles/successful-treatment-of-budd-chiari-syndrome-with-percutaneous-transluminal-balloon-angioplasty.pdf
Read more

Ministernotomy Thymectomy in Mysthania Gravis-Future

Journal of Cardiovascular Medicine and Cardiology Research Article A thymectomy is the surgical removal of the thymus gland. The thymus has been demonstrated to play a role in the development of MG. It is removed in an effort to improve the weakness caused by MG, and to remove a thymoma if present.About 10% of MG patients have a tumor of the thymus called a thymoma. https://www.peertechz.com/articles/ministernotomy-thymectomy-in-mysthania-gravis-future.pdf  
Read more